Research and Markets has announced the addition of the "The Outlook for Medical Devices in Latin America" report to their offering.
The eight Latin American medical markets represent a market of 484 million people with a GDP of U.S.$4.2 trillion in 2010. The region is better prepared to face global instability than in the past but economic growth is expected to slow down in 2010, after a recent period of remarkable growth. The region is now seeing all markets re-evaluate their health provision. Levels of service in the buoyant private health sector are among the best to be found, but the challenge is to provide better levels of basic healthcare to the mass of the population. Opportunities for manufacturers of medical equipment and supplies do exist, but it is knowing where and how to develop them. Mexico is the largest medical market, followed by Brazil, Venezuela and Colombia. Peru is the latest Latin American country to sign an FTA with the U.S.A. Venezuela has tried to align neighbours into a separate bloc but these countries are reliant on U.S. imports.
With the exception of Brazil and Mexico, the edical regulatory environment in the region is less stable than in developed markets. These young markets have not matured yet, therefore their regulatory systems are being consolidated. Brazil and Mexico, however, have more complex and mature regulatory systems. MERCOSUR members tend to follow the medical regulation established by Brazil, and there is some degree of regulatory harmonisation among them. Andean members such as Colombia are also modelling Brazil's medical regulation. Mexico operates closer to its North American allies, and follows the US' FDA regulation.
Trade in medical devices and equipment is key to the region's development with all markets dependent on imports, with the exception of Brazil, which has a strong local domestic industry. Brazil, Argentina, and Chile import more high specification medical technology products, whilst Peru, Mexico and Venezuela import more consumables. Regional medical exports are low, with the exception of Mexico, which represents nearly 90% of the region's export capabilities. Continuing strong export growth in the country is almost entirely due to US manufacturers' maquiladora' activities. Brazil's exports are low compared to the size of its medical market, even though exports have almost doubled in the last five years. The deficit in the balance of trade is negligible for the region, due to the weight of Mexico's exports.
8 Key Markets Covered!
- Argentina
- Brazil
- Chile
- Colombia
- Cuba
- Mexico
- Peru
- Venezuela
MARKET OUTLOOK:
- Current market size
- Unique 5-year market projections to 2012
- Market outlook
- Market structure
- Statistical data on imports and exports
- Market developments, covering recent and impending developments with respect to key issues such as regulation, health facilities, funding, and government policy
- Key national data projections
- International market comparisons
BACKGROUND DATA:
- Population data, including growth trends and age structure
- Demographic indicators detailing principal causes of death and morbidity
HEALTHCARE SYSTEM:
- Organization & administration
- Health expenditure
- Expenditure by source of funding and type
- Hospital services
- Hospital data such as beds by type, region, specialty, patient admissions and surgical procedures
- Outpatient care
- Medical personnel
- Data on healthcare professionals covering such areas as doctors by specialty, nursing staff and dentists
ACCESSING THE MEDICAL MARKET:
- Regulatory environment
- Distribution guide and trade fair information
- Domestic production